mitomycin has been researched along with sphingosine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albino, AP; Dhupar, SK; Ehleiter, D; Fuks, Z; Haimovitz-Friedman, A; Kelsen, DP; Lai, L; Loganzo, F; Maslak, P; Schwartz, GK | 1 |
Hama-Inaba, H; Matsushima, T; Mori, M; Muto, M; Ohyama, H; Saitoh, T; Takusagawa, M; Wang, B; Yamada, T | 1 |
Kepp, O; Kroemer, G; Martins, I; Métivier, D; Michaud, M; Perfettini, JL; Schlemmer, F; Senovilla, L; Séror, C; Tesniere, A; Zitvogel, L | 1 |
Beattie, AR; Levine, MA; Lukowski, ZL; Meyers, CA; Min, J; Samuelson, DA; Schultz, GS; Sherwood, MB; Stoller, G | 1 |
Hu, CY; Lan, KH; Lu, Q; Tang, W; Wang, SF; Yin, GJ | 1 |
5 other study(ies) available for mitomycin and sphingosine
Article | Year |
---|---|
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
Topics: Apoptosis; Drug Resistance; Drug Synergism; Humans; Mitomycin; Protein Kinase C; Sphingosine; Stereoisomerism; Stomach Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Daunorubicin; Drug Resistance; Genetic Variation; Methyl Methanesulfonate; Mice; Mitomycin; Mutagens; Radiation Tolerance; Sphingosine; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Chemotherapy induces ATP release from tumor cells.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Cadmium; Cell Line, Tumor; Cisplatin; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Mice; Mitomycin; Mitoxantrone; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Sphingosine; Thapsigargin | 2009 |
Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.
Topics: Alkylating Agents; Animals; Antibodies, Monoclonal, Humanized; Cicatrix; Conjunctiva; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibrosis; Filtering Surgery; Glaucoma; Injections; Lysophospholipids; Mitomycin; Postoperative Complications; Rabbits; Sphingosine; Surgically-Created Structures; Wound Healing | 2013 |
[Antitumor effect of sphingosine kinase 1 inhibitor in combination with chemotherapy on SGC7901 gastric cancer cells in vitro].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Enzyme Inhibitors; Fluorouracil; Humans; Mitomycin; Phosphotransferases (Alcohol Group Acceptor); Sphingosine; Stomach Neoplasms | 2012 |